{"name": "GlycoMimetics",
 "permalink": "glycomimetics",
 "crunchbase_url": "http://www.crunchbase.com/company/glycomimetics",
 "homepage_url": "http://www.glycomimetics.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2003,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "webmaster@glycomimetics.com",
 "phone_number": "240-243-1201",
 "description": "",
 "created_at": "Thu Oct 22 07:56:31 UTC 2009",
 "updated_at": "Tue Dec 08 05:35:19 UTC 2009",
 "overview": "\u003Cp\u003EGlycoMimetics, Inc., a biopharmaceutical company, engages in the design and development of small molecule therapeutics to mimic the functions of bioactive carbohydrates. Its products include GMI-1070, a synthetic glycomimetic molecule designed to inhibit selectin types, such as E, P, and L-selectin; and GMI-1051, a small molecular weight compound for the treatment or prevention of infections caused by pseudomonas aeruginosa. The company was founded in 2003 and is based in Gaithersburg, Maryland.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       32],
      "assets/images/resized/0006/3384/63384v1-max-150x150.png"],
     [[250,
       54],
      "assets/images/resized/0006/3384/63384v1-max-250x250.png"],
     [[361,
       78],
      "assets/images/resized/0006/3384/63384v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Founder, CEO",
    "person":
     {"first_name": "Rachel",
      "last_name": "K. King",
      "permalink": "rachel-k-king",
      "image": null}},
   {"is_past": false,
    "title": " Chief Scientific Officer and Vice President ",
    "person":
     {"first_name": "John",
      "last_name": "Magnani",
      "permalink": "john-magnani",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$38M",
 "funding_rounds":
  [{"round_code": "c",
    "source_url": "http://onbiovc.com/glycomimetics-inc-series-c-38m/",
    "source_description": "GlycoMimetics, Inc.: Series C $38M",
    "raised_amount": 38000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 12,
    "funded_day": 7,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "New Enterprise Associates",
         "permalink": "new-enterprise-associates",
         "image":
          {"available_sizes":
            [[[150,
               110],
              "assets/images/resized/0001/5083/15083v3-max-150x150.png"],
             [[150,
               110],
              "assets/images/resized/0001/5083/15083v3-max-250x250.png"],
             [[150,
               110],
              "assets/images/resized/0001/5083/15083v3-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Novartis Venture Fund",
         "permalink": "novartis-venture-fund",
         "image":
          {"available_sizes":
            [[[150,
               70],
              "assets/images/resized/0005/9083/59083v2-max-150x150.png"],
             [[250,
               117],
              "assets/images/resized/0005/9083/59083v2-max-250x250.png"],
             [[318,
               150],
              "assets/images/resized/0005/9083/59083v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Anthem Capital Management",
         "permalink": "anthem-capital-management",
         "image":
          {"available_sizes":
            [[[150,
               57],
              "assets/images/resized/0002/1424/21424v1-max-150x150.png"],
             [[171,
               65],
              "assets/images/resized/0002/1424/21424v1-max-250x250.png"],
             [[171,
               65],
              "assets/images/resized/0002/1424/21424v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Alliance Technology Ventures",
         "permalink": "alliance-technology-ventures",
         "image":
          {"available_sizes":
            [[[150,
               45],
              "assets/images/resized/0004/9817/49817v2-max-150x150.jpg"],
             [[250,
               75],
              "assets/images/resized/0004/9817/49817v2-max-250x250.jpg"],
             [[450,
               136],
              "assets/images/resized/0004/9817/49817v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Genzyme Ventures",
         "permalink": "genzyme-ventures",
         "image":
          {"available_sizes":
            [[[150,
               50],
              "assets/images/resized/0002/8655/28655v1-max-150x150.png"],
             [[155,
               52],
              "assets/images/resized/0002/8655/28655v1-max-250x250.png"],
             [[155,
               52],
              "assets/images/resized/0002/8655/28655v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "101 Orchard Ridge Drive",
    "address2": "Suite 1E",
    "zip_code": "20878",
    "city": "Gaithersburg",
    "state_code": "MD",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}